• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于评估抗体与细胞表面靶标相互作用的差异细胞捕获分析方法。

A differential cell capture assay for evaluating antibody interactions with cell surface targets.

机构信息

Department of Molecular and Medical Pharmacology, Crump Institute of Molecular Imaging, California NanoSystems Institute, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

出版信息

Anal Biochem. 2010 Jun 15;401(2):173-81. doi: 10.1016/j.ab.2010.02.015. Epub 2010 Feb 21.

DOI:10.1016/j.ab.2010.02.015
PMID:20178770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4485450/
Abstract

Many biological and biomedical laboratory assays require the use of antibodies and antibody fragments that strongly bind to their cell surface targets. Conventional binding assays, such as the enzyme-linked immunosorbent assay (ELISA) and flow cytometry, have many challenges, including capital equipment requirements, labor intensiveness, and large reagent and sample consumption. Although these techniques are successful in mainstream biology, there is an unmet need for a tool to quickly ascertain the relative binding capabilities of antibodies/antibody fragments to cell surface targets on the benchtop at low cost. We describe a novel cell capture assay that enables several candidate antibodies to be evaluated quickly as to their relative binding efficacies to their cell surface targets. We used chimeric rituximab and murine anti-CD20 monoclonal antibodies as cell capture agents on a functionalized microscope slide surface to assess their relative binding affinities based on how well they capture CD20-expressing mammalian cells. We found that these antibodies' concentration-dependent cell capture profiles correlate with their relative binding affinities. A key observation of this assay involved understanding how differences in capture surfaces affect the assay results. This approach can find utility when an antibody or antibody fragment against a known cell line needs to be selected for targeting studies.

摘要

许多生物和生物医学实验室检测都需要使用能够与细胞表面靶标强烈结合的抗体和抗体片段。传统的结合检测方法,如酶联免疫吸附测定(ELISA)和流式细胞术,存在许多挑战,包括资本设备要求、劳动强度大和试剂和样品消耗量大等问题。尽管这些技术在主流生物学中取得了成功,但仍然需要一种工具来快速确定抗体/抗体片段在低成本下对细胞表面靶标的相对结合能力。我们描述了一种新颖的细胞捕获检测方法,可快速评估几种候选抗体与其细胞表面靶标的相对结合效力。我们使用嵌合利妥昔单抗和鼠抗 CD20 单克隆抗体作为功能化显微镜载玻片表面上的细胞捕获剂,根据它们捕获表达 CD20 的哺乳动物细胞的能力来评估其相对结合亲和力。我们发现这些抗体的浓度依赖性细胞捕获曲线与它们的相对结合亲和力相关。该检测的一个关键观察结果涉及了解捕获表面的差异如何影响检测结果。当需要针对已知细胞系选择针对某个靶标的抗体或抗体片段时,这种方法可能具有实际应用价值。

相似文献

1
A differential cell capture assay for evaluating antibody interactions with cell surface targets.一种用于评估抗体与细胞表面靶标相互作用的差异细胞捕获分析方法。
Anal Biochem. 2010 Jun 15;401(2):173-81. doi: 10.1016/j.ab.2010.02.015. Epub 2010 Feb 21.
2
Expression and biological characterization of an anti-CD20 biosimilar candidate antibody: a case study.抗 CD20 生物类似药候选抗体的表达和生物学特征:案例研究。
MAbs. 2012 Jul-Aug;4(4):488-96. doi: 10.4161/mabs.20761. Epub 2012 Jul 1.
3
Binding to CD20 by anti-B1 antibody or F(ab')(2) is sufficient for induction of apoptosis in B-cell lines.抗B1抗体或F(ab')(2)与CD20结合足以诱导B细胞系发生凋亡。
Cancer Immunol Immunother. 2002 Mar;51(1):15-24. doi: 10.1007/s00262-001-0247-1. Epub 2001 Dec 18.
4
γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody.GA101,一种 II 型糖基化工程抗 CD20 单克隆抗体,可显著增强 γδ T 细胞对原发性滤泡性淋巴瘤细胞的杀伤作用。
Haematologica. 2011 Mar;96(3):400-7. doi: 10.3324/haematol.2010.029520. Epub 2010 Nov 25.
5
HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis.HuMab-7D8,一种针对 CD20 膜近端小环表位的单克隆抗体,能够有效消除抵抗利妥昔单抗介导裂解的低表达 CD20 的肿瘤细胞。
Haematologica. 2010 Dec;95(12):2063-71. doi: 10.3324/haematol.2010.025783. Epub 2010 Sep 17.
6
Binding affinity determination of therapeutic antibodies to membrane protein targets: Kinetic Exclusion Assay using cellular membranes for anti-CD20 antibody.治疗性抗体与膜蛋白靶标的结合亲和力测定:使用细胞膜的动力学排除测定法测定抗 CD20 抗体。
Anal Biochem. 2020 Nov 15;609:113974. doi: 10.1016/j.ab.2020.113974. Epub 2020 Sep 30.
7
Evaluation of a peptide ELISA for the detection of rituximab in serum.用于检测血清中利妥昔单抗的肽酶联免疫吸附测定法的评估
J Immunol Methods. 2007 Aug 31;325(1-2):127-39. doi: 10.1016/j.jim.2007.06.011. Epub 2007 Jul 17.
8
Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method.利用DNA免疫法构建抗B淋巴细胞抗原CD20胞外域的单克隆抗体并进行特性分析。
Int Immunopharmacol. 2017 Feb;43:23-32. doi: 10.1016/j.intimp.2016.11.035. Epub 2016 Dec 7.
9
Design, expression and characterization of a single chain anti-CD20 antibody; a germline humanized antibody derived from Rituximab.一种单链抗CD20抗体的设计、表达及特性分析;一种源自利妥昔单抗的人源化胚系抗体。
Protein Expr Purif. 2014 Oct;102:45-51. doi: 10.1016/j.pep.2014.07.008. Epub 2014 Aug 1.
10
Novel humanized anti-CD20 antibody BM-ca binds to a unique epitope and exerts stronger cellular activity than others.新型人源化抗 CD20 抗体 BM-ca 结合独特表位,比其他抗体具有更强的细胞活性。
Cancer Med. 2013 Apr;2(2):130-43. doi: 10.1002/cam4.60. Epub 2013 Feb 20.

引用本文的文献

1
Point-of-care (POC) devices by means of advanced MEMS.借助先进微机电系统的即时检测(POC)设备。
Talanta. 2015 Dec 1;145:55-9. doi: 10.1016/j.talanta.2015.04.032. Epub 2015 Apr 23.
2
Characterization of cell seeding and specific capture of B cells in microbubble well arrays.微泡井阵列中细胞接种和 B 细胞特异性捕获的特性分析。
Biomed Microdevices. 2013 Jun;15(3):453-63. doi: 10.1007/s10544-013-9745-0.
3
A microfluidic cell concentrator.微流控细胞浓缩器。
Anal Chem. 2010 Oct 1;82(19):8320-6. doi: 10.1021/ac101866p.

本文引用的文献

1
Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope.基于亲和力常数和表位开发新型人源化抗 CD20 抗体。
Cancer Sci. 2010 Jan;101(1):201-9. doi: 10.1111/j.1349-7006.2009.01392.x. Epub 2009 Oct 10.
2
Enhancing the performance of a point-of-care CD4+ T-cell counting microchip through monocyte depletion for HIV/AIDS diagnostics.通过单核细胞耗竭提高即时检测CD4+ T细胞计数微芯片在HIV/AIDS诊断中的性能。
Lab Chip. 2009 May 21;9(10):1357-64. doi: 10.1039/b818813k. Epub 2009 Feb 4.
3
Individual blood-cell capture and 2D organization on microarrays.微阵列上的单个血细胞捕获与二维组织
Small. 2009 Jul;5(13):1493-7. doi: 10.1002/smll.200801941.
4
Recent advances in immobilization methods of antibodies on solid supports.抗体在固体支持物上固定化方法的最新进展。
Analyst. 2008 Jun;133(6):697-701. doi: 10.1039/b800014j. Epub 2008 Apr 17.
5
Isolation of rare circulating tumour cells in cancer patients by microchip technology.利用微芯片技术分离癌症患者体内罕见的循环肿瘤细胞。
Nature. 2007 Dec 20;450(7173):1235-9. doi: 10.1038/nature06385.
6
Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.源自Pten基因缺失的前列腺癌的小鼠细胞系显示了PTEN在激素难治性前列腺癌发展中的关键作用。
Cancer Res. 2007 Jul 1;67(13):6083-91. doi: 10.1158/0008-5472.CAN-06-4202.
7
Antibody engineering and modification technologies.抗体工程与修饰技术
Biomol Eng. 2007 Jun;24(2):201-15. doi: 10.1016/j.bioeng.2007.03.004. Epub 2007 Mar 31.
8
Structural basis for recognition of CD20 by therapeutic antibody Rituximab.治疗性抗体利妥昔单抗识别CD20的结构基础。
J Biol Chem. 2007 May 18;282(20):15073-80. doi: 10.1074/jbc.M701654200. Epub 2007 Mar 29.
9
Panning of multiple subsets of leukocytes on antibody-decorated poly(ethylene) glycol-coated glass slides.在抗体修饰的聚乙二醇包被载玻片上淘选多种白细胞亚群。
J Immunol Methods. 2006 Jun 30;313(1-2):96-109. doi: 10.1016/j.jim.2006.03.017. Epub 2006 Jun 8.
10
The epitope recognized by rituximab.利妥昔单抗识别的表位。
Blood. 2006 Sep 15;108(6):1975-8. doi: 10.1182/blood-2006-04-014639. Epub 2006 May 16.